tiprankstipranks
Abbott Laboratories (ABT)
NYSE:ABT
US Market
ABT
Abbott Laboratories
RESEARCH TOOLSreports
Want to see ABT full AI Analyst Report?

Abbott Laboratories (ABT) Stock Forecast & Price Target

9,318 Followers
See the Price Targets and Ratings of:

ABT Analyst Ratings

Strong Buy
18Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Abbott
Laboratories
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ABT Stock 12 Month Forecast

Average Price Target

$119.31
▲(23.24% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Abbott Laboratories in the last 3 months. The average price target is $119.31 with a high forecast of $143.00 and a low forecast of $92.00. The average price target represents a 23.24% change from the last price of $96.81.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"86":"$86","115":"$115","144":"$144","100.5":"$100.5","129.5":"$129.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$143.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":119.3125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$119.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$92.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[86,100.5,115,129.5,144],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.527,95.48646153846154,99.44592307692308,103.40538461538462,107.36484615384616,111.3243076923077,115.28376923076922,119.24323076923076,123.2026923076923,127.16215384615384,131.12161538461538,135.08107692307692,139.04053846153846,{"y":143,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.527,93.66434615384615,95.8016923076923,97.93903846153846,100.07638461538461,102.21373076923076,104.35107692307692,106.48842307692308,108.62576923076924,110.76311538461539,112.90046153846154,115.0378076923077,117.17515384615385,{"y":119.3125,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,91.527,91.56338461538462,91.59976923076923,91.63615384615385,91.67253846153847,91.70892307692307,91.74530769230769,91.78169230769231,91.81807692307693,91.85446153846154,91.89084615384616,91.92723076923077,91.96361538461538,{"y":92,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":132.586,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.414,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":129.663,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.454,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.364,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.674,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.004,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.957,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.605,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.021,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.826,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.158,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.527,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$143.00Average Price Target$119.31Lowest Price Target$92.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on ABT
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$135
Buy
39.45%
Upside
Reiterated
07/17/26
Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Raymond James Analyst forecast on ABT
Jayson Bedford
Raymond James
Raymond James
―
Buy
―
Reiterated
07/17/26
Abbott Laboratories (ABT) Gets a Buy from Raymond James
Piper Sandler Analyst forecast on ABT
Adam Maeder
Piper Sandler
Piper Sandler
$115→$118
Buy
21.89%
Upside
Reiterated
07/17/26
Abbott Laboratories (ABT) Receives a Buy from Piper Sandler
J.P. Morgan Analyst forecast on ABT
Robbie Marcus
J.P. Morgan
J.P. Morgan
$110→$120
Buy
23.95%
Upside
Reiterated
07/17/26
Abbott price target raised to $120 from $110 at JPMorganAbbott price target raised to $120 from $110 at JPMorgan
Wells Fargo Analyst forecast on ABT
Larry Biegelsen
Wells Fargo
Wells Fargo
$109→$112
Buy
15.69%
Upside
Assigned
07/17/26
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), Insmed (INSM)
Citi Analyst forecast on ABT
Joanne Wuensch
Citi
Citi
$108→$112
Buy
15.69%
Upside
Reiterated
07/17/26
Abbott price target raised to $112 from $108 at CitiAbbott price target raised to $112 from $108 at Citi
TD Cowen Analyst forecast on ABT
Josh Jennings
TD Cowen
TD Cowen
$115
Buy
18.79%
Upside
Reiterated
07/16/26
TD Cowen Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Bank of America Securities Analyst forecast on ABT
Travis Steed
Bank of America Securities
Bank of America Securities
$102
Buy
5.36%
Upside
Reiterated
07/16/26
Abbott Laboratories (ABT) Receives a Buy from Bank of America Securities
RBC Capital Analyst forecast on ABT
Shagun Singh Chadha
RBC Capital
RBC Capital
$130
Buy
34.28%
Upside
Reiterated
07/16/26
RBC Capital Sticks to Their Buy Rating for Abbott Laboratories (ABT)
William Blair Analyst forecast on ABT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
07/16/26
Analysts' Top Healthcare Picks: Alpha Tau Medical Ltd (DRTS), Abbott Laboratories (ABT)
BTIG Analyst forecast on ABT
Marie Thibault
BTIG
BTIG
$131→$134
Buy
38.42%
Upside
Reiterated
07/16/26
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT)
Evercore ISI Analyst forecast on ABT
Vijay Kumar
Evercore ISI
Evercore ISI
$120→$112
Buy
15.69%
Upside
Reiterated
07/06/26
Abbott price target lowered to $112 from $120 at Evercore ISIAbbott price target lowered to $112 from $120 at Evercore ISI
Robert W. Baird Analyst forecast on ABT
David Rescott
Robert W. Baird
Robert W. Baird
$121
Buy
24.99%
Upside
Initiated
06/30/26
Abbott initiated with an Outperform at BairdAbbott initiated with an Outperform at Baird
Goldman Sachs Analyst forecast on ABT
David Roman
Goldman Sachs
Goldman Sachs
$121→$113
Buy
16.72%
Upside
Reiterated
05/31/26
Abbott Laboratories: Buy Rating Reaffirmed on Improving 2026 Growth Outlook and Margin Expansion Potential, with Price Target Trimmed to $113
Daiwa Analyst forecast on ABT
Narumi Nakagiri
Daiwa
Daiwa
$113→$92
Hold
-4.97%
Downside
Downgraded
04/21/26
Abbott downgraded to Neutral from Outperform at DaiwaAbbott downgraded to Neutral from Outperform at Daiwa
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on ABT
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$135
Buy
39.45%
Upside
Reiterated
07/17/26
Jefferies Reaffirms Their Buy Rating on Abbott Laboratories (ABT)
Raymond James Analyst forecast on ABT
Jayson Bedford
Raymond James
Raymond James
―
Buy
―
Reiterated
07/17/26
Abbott Laboratories (ABT) Gets a Buy from Raymond James
Piper Sandler Analyst forecast on ABT
Adam Maeder
Piper Sandler
Piper Sandler
$115→$118
Buy
21.89%
Upside
Reiterated
07/17/26
Abbott Laboratories (ABT) Receives a Buy from Piper Sandler
J.P. Morgan Analyst forecast on ABT
Robbie Marcus
J.P. Morgan
J.P. Morgan
$110→$120
Buy
23.95%
Upside
Reiterated
07/17/26
Abbott price target raised to $120 from $110 at JPMorganAbbott price target raised to $120 from $110 at JPMorgan
Wells Fargo Analyst forecast on ABT
Larry Biegelsen
Wells Fargo
Wells Fargo
$109→$112
Buy
15.69%
Upside
Assigned
07/17/26
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), Insmed (INSM)
Citi Analyst forecast on ABT
Joanne Wuensch
Citi
Citi
$108→$112
Buy
15.69%
Upside
Reiterated
07/17/26
Abbott price target raised to $112 from $108 at CitiAbbott price target raised to $112 from $108 at Citi
TD Cowen Analyst forecast on ABT
Josh Jennings
TD Cowen
TD Cowen
$115
Buy
18.79%
Upside
Reiterated
07/16/26
TD Cowen Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Bank of America Securities Analyst forecast on ABT
Travis Steed
Bank of America Securities
Bank of America Securities
$102
Buy
5.36%
Upside
Reiterated
07/16/26
Abbott Laboratories (ABT) Receives a Buy from Bank of America Securities
RBC Capital Analyst forecast on ABT
Shagun Singh Chadha
RBC Capital
RBC Capital
$130
Buy
34.28%
Upside
Reiterated
07/16/26
RBC Capital Sticks to Their Buy Rating for Abbott Laboratories (ABT)
William Blair Analyst forecast on ABT
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
07/16/26
Analysts' Top Healthcare Picks: Alpha Tau Medical Ltd (DRTS), Abbott Laboratories (ABT)
BTIG Analyst forecast on ABT
Marie Thibault
BTIG
BTIG
$131→$134
Buy
38.42%
Upside
Reiterated
07/16/26
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT)
Evercore ISI Analyst forecast on ABT
Vijay Kumar
Evercore ISI
Evercore ISI
$120→$112
Buy
15.69%
Upside
Reiterated
07/06/26
Abbott price target lowered to $112 from $120 at Evercore ISIAbbott price target lowered to $112 from $120 at Evercore ISI
Robert W. Baird Analyst forecast on ABT
David Rescott
Robert W. Baird
Robert W. Baird
$121
Buy
24.99%
Upside
Initiated
06/30/26
Abbott initiated with an Outperform at BairdAbbott initiated with an Outperform at Baird
Goldman Sachs Analyst forecast on ABT
David Roman
Goldman Sachs
Goldman Sachs
$121→$113
Buy
16.72%
Upside
Reiterated
05/31/26
Abbott Laboratories: Buy Rating Reaffirmed on Improving 2026 Growth Outlook and Margin Expansion Potential, with Price Target Trimmed to $113
Daiwa Analyst forecast on ABT
Narumi Nakagiri
Daiwa
Daiwa
$113→$92
Hold
-4.97%
Downside
Downgraded
04/21/26
Abbott downgraded to Neutral from Outperform at DaiwaAbbott downgraded to Neutral from Outperform at Daiwa
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OCGNOcugen
TARAProtara Therapeutics
MIRMMirum Pharmaceuticals
CSTLCastle Biosciences
PCVXVaxcyte
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Abbott Laboratories

3 Months
Matthew TaylorJefferies
Success Rate
16/21 ratings generated profit
76%
Average Return
+3.42%
Copying Matthew Taylor's trades and holding each position for 3 Months would result in 76.19% of your transactions generating a profit, with an average return of +3.42% per trade.
1 Year
Jayson BedfordRaymond James
Success Rate
34/43 ratings generated profit
79%
Average Return
+16.01%
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 79.07% of your transactions generating a profit, with an average return of +16.01% per trade.
2 Years
Matthew TaylorJefferies
Success Rate
15/21 ratings generated profit
71%
Average Return
+29.03%
Copying Matthew Taylor's trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +29.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABT Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
1
0
0
0
0
Buy
32
38
35
42
33
Hold
2
6
6
5
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
44
41
47
33
In the current month, ABT has received 33 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ABT average Analyst price target in the past 3 months is 119.31.
Each month's total comprises the sum of three months' worth of ratings.

ABT Financial Forecast

ABT Earnings Forecast

Next quarter’s earnings estimate for ABT is $1.42 with a range of $1.40 to $1.45. The previous quarter’s EPS was $1.31. ABT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year ABT has Performed in-line its overall industry.
Next quarter’s earnings estimate for ABT is $1.42 with a range of $1.40 to $1.45. The previous quarter’s EPS was $1.31. ABT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year ABT has Performed in-line its overall industry.

ABT Sales Forecast

Next quarter’s sales forecast for ABT is $13.01B with a range of $12.89B to $13.18B. The previous quarter’s sales results were $12.59B. ABT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year ABT has Performed in-line its overall industry.
Next quarter’s sales forecast for ABT is $13.01B with a range of $12.89B to $13.18B. The previous quarter’s sales results were $12.59B. ABT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year ABT has Performed in-line its overall industry.

ABT Stock Forecast FAQ

What is ABT’s average 12-month price target, according to analysts?
Based on analyst ratings, Abbott Laboratories’s 12-month average price target is 119.31.
    What is ABT’s upside potential, based on the analysts’ average price target?
    Abbott Laboratories has 23.24% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ABT a Buy, Sell or Hold?
          Abbott Laboratories has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Abbott Laboratories’s price target?
            The average price target for Abbott Laboratories is 119.31. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $143.00 ,the lowest forecast is $92.00. The average price target represents 23.24% Increase from the current price of $96.81.
              What do analysts say about Abbott Laboratories?
              Abbott Laboratories’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of ABT?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.